Market Cap: $3.48M
CI
Co-Diagnostics, Inc.
CODX
NASDAQUSD
Market Cap: $3.48M
CoDiagnostics Expands its Footprint in Saudi Arabia's Molecular Diagnostics Sector CoDiagnostics, Inc., through its joint venture CoMira Diagnostics, marks a significant milestone with the recent allo…
CoDiagnostics Advances Tuberculosis Testing with Innovative Solutions CoDiagnostics, Inc. is set to enhance tuberculosis (TB) diagnostic capabilities through the anticipated launch of clinical perform…
CoSara Aims to Transform Healthcare with Advanced Diagnostic Solutions in India CoSara, the joint venture between Co-Diagnostics, Inc. (Co-Dx) and Ambalal Sarabhai Enterprises Limited, is poised to re…
CoDiagnostics Strengthens International Presence at Medical Korea 2026 CoDiagnostics, Inc., a leader in molecular diagnostics, prepares to showcase its innovative diagnostic solutions at Medical Korea…
CoDiagnostics Strengthens Global Presence at Medical Korea 2026 CoDiagnostics, Inc. (Nasdaq: CODX), a leader in molecular diagnostics, is set to make a notable impact at Medical Korea 2026, a prominen…
CoDiagnostics Strengthens Intellectual Property Portfolio with Recent Patent in Japan CoDiagnostics, Inc. (Nasdaq: CODX), a leader in molecular diagnostics, achieves a significant milestone with the g…
CoDiagnostics Breaks Ground with Japanese Patent for Advanced Diagnostic Platform CoDiagnostics, Inc. (Nasdaq: CODX), a leading player in the molecular diagnostics sector, receives a significant boost…
CoDiagnostics Achieves Nasdaq Compliance and Focus on Innovative Diagnostic Solutions CoDiagnostics, Inc., a Utah-based molecular diagnostics enterprise, announces its regained compliance with Nasdaq…
CoDiagnostics Achieves Nasdaq Compliance, Set to Advance PCR Platform Development CoDiagnostics, Inc., a molecular diagnostics company based in Utah, announces its recent compliance with Nasdaq listin…
Co-Diagnostics pushes regional manufacturing via CoMira at Dubai expo SALT LAKE CITY — Co-Diagnostics is using a major regional trade show to press its plan to localize manufacturing and distribution…
CoSara Diagnostics Expands Distributor Network in India to Enhance Diagnostic Reach Co-Diagnostics, Inc. continues to solidify its foothold in the Indian molecular diagnostics market through its joint…
CoSara Diagnostics Expands Its Distributor Network in India to Enhance Diagnostic Solutions Co-Diagnostics, Inc. announces a significant development through its Indian joint venture, CoSara Diagnostic…
CoDiagnostics Implements Reverse Stock Split to Ensure Nasdaq Compliance CoDiagnostics, Inc., a Utah-based molecular diagnostics company, announces a strategic move to implement a reverse stock split…
Co-Diagnostics Secures Patent for Innovative PCR Testing Platform CoDiagnostics, Inc., a leader in molecular diagnostics, achieves a significant milestone with the granting of Australian Patent No. AU…
Co-Diagnostics Secures Patented Technology for Innovative PCR Testing CoDiagnostics, Inc. has achieved a significant milestone with the granting of its first patent for the Co-Dx PCR platform by the A…
CoDiagnostics Strengthens Commitment to Global Health Through Advanced TB Diagnostics Course Participation CoDiagnostics, Inc., a molecular diagnostics leader based in Utah, announces its joint ventur…
CoDiagnostics Strengthens Influenza Testing Amid Rising Health Concerns CoDiagnostics, Inc. (Nasdaq: CODX) recently announces pivotal developments in its diagnostic testing capabilities, particularly…
CoDiagnostics Strengthens Influenza Detection Amid Rising Health Concerns CoDiagnostics, Inc., a molecular diagnostics firm, announces the successful completion of an in silico analysis of the Co-Prim…
CoDiagnostics Advances Diagnostic Technologies for Infectious Diseases CoDiagnostics, a biotechnology company specializing in molecular diagnostics, continues to innovate in the field of infectious di…
CoDiagnostics Strengthens Its Position in Infectious Disease Testing CoDiagnostics, a biotechnology company specializing in molecular diagnostics, announces the expansion of its product offerings with…
CoDiagnostics Expands Global Reach with Joint Venture in Saudi Arabia CoDiagnostics, Inc., a Utah-based leader in molecular diagnostics, has announced the formation of CoMira Diagnostics, a joint vent…
Co-Diagnostics Explores Strategic Path for Indian Joint Venture CoSara Diagnostics Co-Diagnostics, Inc. announces a significant strategic development as it appoints Maxim Group LLC as its exclusive fi…
CoDiagnostics Expands Global Reach with Strategic Partnership in the Middle East CoDiagnostics, Inc., a pioneering molecular diagnostics company based in Utah, is solidifying its position in the globa…
CoDiagnostics Expands Through Strategic Joint Venture in Saudi Arabia CoDiagnostics, Inc. (Nasdaq: CODX), a prominent player in the molecular diagnostics sector, announces a significant strategic deve…
CoDiagnostics Partners with Arabian Eagle to Enhance Diagnostic Solutions in Saudi Arabia CoDiagnostics, Inc. (NASDAQ: CODX) recently announces a significant joint venture with Arabian Eagle Manufactu…